维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="BHR"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Comparison of different insulin regimens in elderly patients with NIDDM显示文摘	Wolffenbutted BHR Sels JPJE Rondas-Colbers GJWM	1996	Diabetes Care1996，19，：	1
2	Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels显示文摘	Wolffenbuttel BHR Leurs P Sels JPJE	1993	Diabet Med1993，10，：	1
3	Cyclin-dependent kinase 5(cdk5)and neuronal cell death显示文摘	Weishaupt J H Neusch C Bhr M	2003	Cell Tissue Res2003，312，98：	1
4	Linseed and soybean oil-based polyurethanes prepared via the non-isocyanate route and catalytic carbon dioxide conversion 显示文摘	BHR M MLHAUPT R	2012	Green Chemistry2012，14，：	1
5	Bevacizumab-induced diffusion- restricted lesions in malignant glioma patients 显示文摘	Rieger J Bhr O MUller K	2010	J Neurooncol2010，99，1：	1
6	Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes : CORALL studay 显示文摘	Wolffenbuttel BHR Franken AAM Vincent HH	2005	Intern Med2005，257，6：	1
7	Addition of lowdose rosiglitazone to sulfonylurea therapy improves glycaemic control intrpe 2 diabetic patients显示文摘	Wolffenbuttel BHR Gomist R Squatrito S	2000	Diabetic Med2000，17，1：	1
8	Development of new microsatellite markers from mango(Mangifera indica)and cross-species amplification显示文摘	RAVISHANKAR KV MANI BHR ANAND L	2011	American Journal of Botany2011，98，：	1
9	Addition of low-dose rosiglitazone to sulphontlurea therapy improves glycemic control in type 2 diabetic patients显示文摘	Gomis R Squatrito S	2000	Diabet Med2000，17，：	1
10	A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for treatment of type 2 diabetes显示文摘	Landgraf R	1999	Diabetes Care1999，22，：	1
11	Differential utilization of ketone bodies by neurons and glioma cell lines:a rationale for ketogenic diet as experimental glioma therapy显示文摘	Maurer GD Brucker DP Bhr O	2011	BMC Cancer2011，11，1：	1
12	Additiono flowo serosi glitazone tosul fony lureather apyim proves glycaemic conrolin trpe 2 diabetic patients显示文摘	Wolffen buttel BHR GomistR SquatritoS	2000	Diabetic Med2000，17，1：	1
13	Addition of lowdose rosiglitazone to sulphonglarea therapy improves glycamic control in type 2 diabetic patients显示文摘	Wolffenbuttel BHR Gomistr Squatrito S	2000	Diaket Med2000，17，1：	1
14	DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy(DURABLE)Trial 24-Week Results显示文摘	Buse JB Wolffenbut el BHR Herman WH		0，，06：	1
15	Addition of lowdose rosiglitazone tosulphonglarea therapy improves glycamic control in type 2 cliubetic patients显示文摘	Wolffenbuttel BHR Gomistr Squatrito S	2000	Diaket Med2000，17，1：	1
16	The prognosis of cryptogenic fibrosing alveolitis显示文摘	Stack BHR Choo - Kang YFJ Heard BE	1972	Thorax1972，27，：	1
17	Modes of governance : towards a conceptual clarification显示文摘	TREIB O BHR H FALKNER G	2007	Journal of European Public Policy2007，14，1：	1
18	Addition of low-dose rosiglitazone to sulfonylurea therapy improves glycaemic control in type 2 diabetic patients显示文摘	Wolffrenbuttel BHR Gomist R Squatrito S	2000	Diabetic Med2000，17，：	1
19	A 1-year multicenterr and omized double-blind comparisonofre paglinide and glyburide for treatment of type 2 diabetes显示文摘	Wolffenbattel BHR Landgraf R	1999	Diabetes Care1999，22，：	1
20	Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels显示文摘	Wolffenbuttle BHR Leurs P Sels JPJE	1993	Diabetes Med1993，10，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示